首页 > 最新文献

Heart, Lung and Circulation最新文献

英文 中文
Diabetes is an Increasingly Common Issue After Heart Transplantation: A Case for Integrated Diabetes Care 糖尿病是心脏移植后日益常见的问题:糖尿病综合护理的一个案例。
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-01 DOI: 10.1016/j.hlc.2025.04.081
Lisa M. Raven MBBS , Andrew Jabbour PhD , Peter S. Macdonald PhD , Jerry R. Greenfield PhD , Christopher A. Muir PhD

Background

Orthotopic heart transplantation (OHT) survival rates have improved with advances in immunosuppression over the last 20 years. With these improvements, there has been a greater focus on post-transplant care. Diabetes is common after transplantation and may be pre-existing (type 2 diabetes mellitus [T2DM]) or develop after transplant (post-transplant diabetes mellitus [PTDM]). The aim of this study was to compare the incidence and prevalence of diabetes in OHT recipients in two cohorts separated by 20 years.

Methods

Retrospective audit comparing the prevalence of T2DM and cumulative 2-year incidence of PTDM in 88 consecutive OHT recipients in 1996–1998 and 141 consecutive OHT recipients in 2015–2018 at the same tertiary referral teaching hospital.

Results

The prevalence of pre-transplant T2DM at the time of OHT increased three-fold between 1998 and 2018, from 6% (n=5) to 18% (n=25) respectively (p=0.009). Similarly, the incidence of PTDM increased from 16% (n=13) in 1998 to 36% (n=42) in 2018 (p=0.001). OHT recipients who developed PTDM were older in 2018 vs 1998 (mean age 52 [±11] vs 44 [±9] years; p=0.03). The mean age was not different between individuals with T2DM between the 1998 and 2018 eras. Body mass index was not different between the 1998 and 2018 eras in any of the diabetes status subgroups.

Conclusions

The incidence and prevalence of diabetes after OHT at our Australian institution has increased over 20 years. With improved OHT survival and rates of diabetes, endocrinologists should be incorporated into the care teams of heart transplant recipients. Further studies of glucose-lowering therapies in patients with diabetes after transplantation are warranted.
背景:在过去的20年里,随着免疫抑制技术的进步,原位心脏移植(OHT)的存活率有所提高。随着这些改进,移植后的护理得到了更多的关注。糖尿病在移植后很常见,可能已经存在(2型糖尿病[T2DM]),也可能在移植后发展(移植后糖尿病[PTDM])。本研究的目的是比较两组间隔20年的OHT接受者中糖尿病的发病率和患病率。方法:回顾性审计比较同一三级转诊教学医院1996-1998年连续接受OHT治疗的88名患者和2015-2018年连续接受OHT治疗的141名患者的T2DM患病率和2年累计PTDM发病率。结果:移植前T2DM在OHT时的患病率在1998年至2018年间增加了三倍,分别从6% (n=5)增加到18% (n=25) (p=0.009)。同样,PTDM的发病率从1998年的16% (n=13)增加到2018年的36% (n=42) (p=0.001)。2018年发生PTDM的OHT受者比1998年更老(平均年龄52[±11]岁比44[±9]岁;p=0.03)。1998年至2018年期间,T2DM患者的平均年龄没有差异。在任何糖尿病状态亚组中,1998年和2018年之间的体重指数没有差异。结论:20年来,我们澳大利亚机构OHT后糖尿病的发病率和患病率有所增加。随着OHT存活率和糖尿病发病率的提高,内分泌科医生应该被纳入心脏移植受者的护理团队。移植后糖尿病患者降糖治疗的进一步研究是有必要的。
{"title":"Diabetes is an Increasingly Common Issue After Heart Transplantation: A Case for Integrated Diabetes Care","authors":"Lisa M. Raven MBBS ,&nbsp;Andrew Jabbour PhD ,&nbsp;Peter S. Macdonald PhD ,&nbsp;Jerry R. Greenfield PhD ,&nbsp;Christopher A. Muir PhD","doi":"10.1016/j.hlc.2025.04.081","DOIUrl":"10.1016/j.hlc.2025.04.081","url":null,"abstract":"<div><h3>Background</h3><div>Orthotopic heart transplantation (OHT) survival rates have improved with advances in immunosuppression over the last 20 years. With these improvements, there has been a greater focus on post-transplant care. Diabetes is common after transplantation and may be pre-existing (type 2 diabetes mellitus [T2DM]) or develop after transplant (post-transplant diabetes mellitus [PTDM]). The aim of this study was to compare the incidence and prevalence of diabetes in OHT recipients in two cohorts separated by 20 years.</div></div><div><h3>Methods</h3><div>Retrospective audit comparing the prevalence of T2DM and cumulative 2-year incidence of PTDM in 88 consecutive OHT recipients in 1996–1998 and 141 consecutive OHT recipients in 2015–2018 at the same tertiary referral teaching hospital.</div></div><div><h3>Results</h3><div>The prevalence of pre-transplant T2DM at the time of OHT increased three-fold between 1998 and 2018, from 6% (n=5) to 18% (n=25) respectively (p=0.009). Similarly, the incidence of PTDM increased from 16% (n=13) in 1998 to 36% (n=42) in 2018 (p=0.001). OHT recipients who developed PTDM were older in 2018 vs 1998 (mean age 52 [±11] vs 44 [±9] years; p=0.03). The mean age was not different between individuals with T2DM between the 1998 and 2018 eras. Body mass index was not different between the 1998 and 2018 eras in any of the diabetes status subgroups.</div></div><div><h3>Conclusions</h3><div>The incidence and prevalence of diabetes after OHT at our Australian institution has increased over 20 years. With improved OHT survival and rates of diabetes, endocrinologists should be incorporated into the care teams of heart transplant recipients. Further studies of glucose-lowering therapies in patients with diabetes after transplantation are warranted.</div></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 11","pages":"Pages 1290-1294"},"PeriodicalIF":2.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145182029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Utility of Infrared Thermography and Hyperspectral Imaging in Peripheral Artery Disease: A Systematic Review 红外热成像和高光谱成像在外周动脉疾病中的应用:系统综述。
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-01 DOI: 10.1016/j.hlc.2025.03.017
Olavi Yli-Harja BM , Tomppa Pakarinen DSc , Emmi Peltola MSc , Meri Hämäläinen MSc , Antti Vehkaoja DSc , Niku Oksala MD, PhD, DSc

Background

Peripheral artery disease (PAD) is a prevalent vascular disorder that reduces blood flow and tissue oxygenation. Early detection is crucial to optimise treatment outcomes and minimise ulceration or gangrene and possible subsequent amputations. This systematic review evaluated the diagnostic significance and clinical utility of infrared thermography (IRT) and hyperspectral imaging (HSI) as non-invasive, contactless techniques for PAD and chronic limb-threatening ischaemia assessment. Infrared thermography assesses blood perfusion by detecting temperature changes in limbs and HSI can be utilised to evaluate oxygen saturation, and deoxyhaemoglobin and oxyhaemoglobin concentrations in superficial tissue.

Methods

After a comprehensive PubMed literature search, a total of 15 articles were included in the final analysis: eight studies utilising IRT for circulation assessment, six studies employing HSI, and one study combining the two. A total 607 participants with PAD were included.

Results

In the IRT studies, varying levels of correlations were found between established assessment modalities and temperature changes. Significant, but mostly modest, correlations were discovered in the HSI studies—particularly with deoxyhaemoglobin, oxyhaemoglobin, and the ankle–brachial index—making the clinical significance of the results unclear, but still suggesting that HSI has potential for assessing and screening PAD. Head-to-head, HSI accurately detected immediate perfusion changes after PAD treatment, while IRT did not, suggesting that HSI-derived parameters may be more precise for perfusion assessment.

Conclusions

The results indicate that both IRT and HSI hold promise for assessing circulation, oxygenation, and perfusion in participants with vascular deficiency. Further research with larger sample sizes and standardised measurement protocols is needed to validate the clinical utility of IRT and HSI.
背景:外周动脉疾病(PAD)是一种常见的血管疾病,可减少血流量和组织氧合。早期发现对于优化治疗效果和减少溃疡或坏疽以及可能的后续截肢至关重要。本系统综述评估了红外热成像(IRT)和高光谱成像(HSI)作为非侵入性、非接触式技术在PAD和慢性肢体威胁缺血评估中的诊断意义和临床应用。红外热成像通过检测四肢的温度变化来评估血液灌注,HSI可用于评估氧饱和度,以及浅表组织中的脱氧血红蛋白和氧合血红蛋白浓度。方法:经过全面的PubMed文献检索,最终分析共纳入15篇文章:8项研究使用IRT进行循环评估,6项研究使用HSI, 1项研究将两者结合。共纳入607名PAD患者。结果:在IRT研究中,在已建立的评估模式和温度变化之间发现了不同程度的相关性。在HSI研究中发现了显著的,但大多是适度的相关性,特别是与脱氧血红蛋白、氧合血红蛋白和踝-肱指数之间的相关性,这使得结果的临床意义不明确,但仍然表明HSI具有评估和筛查PAD的潜力。头对头,HSI能准确检测PAD治疗后的即时灌注变化,而IRT不能,这表明HSI衍生的参数可能更准确地用于灌注评估。结论:结果表明,IRT和HSI都有望评估血管缺乏参与者的循环、氧合和灌注。进一步的研究需要更大的样本量和标准化的测量方案来验证IRT和HSI的临床应用。
{"title":"The Utility of Infrared Thermography and Hyperspectral Imaging in Peripheral Artery Disease: A Systematic Review","authors":"Olavi Yli-Harja BM ,&nbsp;Tomppa Pakarinen DSc ,&nbsp;Emmi Peltola MSc ,&nbsp;Meri Hämäläinen MSc ,&nbsp;Antti Vehkaoja DSc ,&nbsp;Niku Oksala MD, PhD, DSc","doi":"10.1016/j.hlc.2025.03.017","DOIUrl":"10.1016/j.hlc.2025.03.017","url":null,"abstract":"<div><h3>Background</h3><div>Peripheral artery disease (PAD) is a prevalent vascular disorder that reduces blood flow and tissue oxygenation. Early detection is crucial to optimise treatment outcomes and minimise ulceration or gangrene and possible subsequent amputations. This systematic review evaluated the diagnostic significance and clinical utility of infrared thermography (IRT) and hyperspectral imaging (HSI) as non-invasive, contactless techniques for PAD and chronic limb-threatening ischaemia assessment. Infrared thermography assesses blood perfusion by detecting temperature changes in limbs and HSI can be utilised to evaluate oxygen saturation, and deoxyhaemoglobin and oxyhaemoglobin concentrations in superficial tissue.</div></div><div><h3>Methods</h3><div>After a comprehensive PubMed literature search, a total of 15 articles were included in the final analysis: eight studies utilising IRT for circulation assessment, six studies employing HSI, and one study combining the two. A total 607 participants with PAD were included.</div></div><div><h3>Results</h3><div>In the IRT studies, varying levels of correlations were found between established assessment modalities and temperature changes. Significant, but mostly modest, correlations were discovered in the HSI studies—particularly with deoxyhaemoglobin, oxyhaemoglobin, and the ankle–brachial index—making the clinical significance of the results unclear, but still suggesting that HSI has potential for assessing and screening PAD. Head-to-head, HSI accurately detected immediate perfusion changes after PAD treatment, while IRT did not, suggesting that HSI-derived parameters may be more precise for perfusion assessment.</div></div><div><h3>Conclusions</h3><div>The results indicate that both IRT and HSI hold promise for assessing circulation, oxygenation, and perfusion in participants with vascular deficiency. Further research with larger sample sizes and standardised measurement protocols is needed to validate the clinical utility of IRT and HSI.</div></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 11","pages":"Pages 1194-1208"},"PeriodicalIF":2.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144855097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validating Biventricular Pressure–Volume Loop–Derived Cardiac Output Against Thermodilution: A Step Towards Precision Haemodynamic Assessment 验证双心室压力-容积循环衍生的心输出量对抗热稀释:迈向精确血流动力学评估的一步
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-01 DOI: 10.1016/j.hlc.2025.10.004
Mohammad Sarraf MD , Vinayak Nagaraja MBBS, MBiostat, FRACP
{"title":"Validating Biventricular Pressure–Volume Loop–Derived Cardiac Output Against Thermodilution: A Step Towards Precision Haemodynamic Assessment","authors":"Mohammad Sarraf MD ,&nbsp;Vinayak Nagaraja MBBS, MBiostat, FRACP","doi":"10.1016/j.hlc.2025.10.004","DOIUrl":"10.1016/j.hlc.2025.10.004","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 11","pages":"Pages 1147-1149"},"PeriodicalIF":2.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145478818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unilateral Versus Bilateral Antegrade Cerebral Perfusion in Aortic Arch Surgery: Systematic Review and Meta-Analysis of Randomised Controlled Trials and Propensity-Matched Studies 主动脉弓手术中单侧与双侧顺行脑灌注:随机对照试验和倾向匹配研究的系统评价和荟萃分析
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-01 DOI: 10.1016/j.hlc.2025.03.018
Kristine Santos BSc , Emmanuel Mark Velasco MD , Mohammad Mawasi , Tomasz Płonek MD, PhD, FEBCTS(cardiac)

Background

Selective antegrade cerebral perfusion, via unilateral antegrade cerebral perfusion (uACP) or bilateral antegrade cerebral perfusion (bACP) approaches, is used in aortic arch surgery to protect the brain during circulatory arrest. Previous meta-analyses, based on unmatched observational data, found no differences between these techniques. Our updated meta-analysis exclusively examines high-quality evidence from randomised controlled trials and propensity-matched studies.

Method

A literature search of MEDLINE, Scopus, and Cochrane databases identified relevant studies up to November 2024. Pooled odds ratios (ORs) and mean differences with 95% confidence intervals (CIs) were calculated using RevMan version 8.13.0.

Results

We included eight studies comprising 2,072 patients, with 1,025 (49.5%) patients in the uACP group. The pooled analysis revealed that uACP was associated with a shorter hospital length of stay (mean differences −2.2 days; 95% CI −3.6 to −0.7; p<0.05) and a reduced incidence of permanent neurological dysfunction (OR 0.7; 95% CI 0.5 to 0.9; p<0.05). However, uACP was linked to a higher incidence of acute kidney injury (OR 1.5; 95% CI 1.1 to 2.0; p<0.05). No statistically significant differences were observed between uACP and bACP in terms of aortic cross-clamp time, cardiopulmonary bypass duration, ventilation time, transient neurological deficits, intensive care unit length of stay, 30-day mortality, and re-exploration for bleeding.

Conclusions

Our meta-analysis confirmed several comparable outcomes between uACP and bACP as reported in previous reviews. However, our study identified additional findings, such as a reduced hospital length of stay and lower incidence of permanent neurological dysfunction associated with uACP, alongside a higher risk of acute kidney injury.
背景:选择性顺行脑灌注,通过单侧顺行脑灌注(uACP)或双侧顺行脑灌注(bACP)入路,在主动脉弓手术中用于保护循环停止时的大脑。先前的荟萃分析,基于不匹配的观察数据,发现这些技术之间没有差异。我们最新的荟萃分析专门检查了来自随机对照试验和倾向匹配研究的高质量证据。方法:检索MEDLINE、Scopus和Cochrane数据库,检索截至2024年11月的相关研究。使用RevMan version 8.13.0计算合并优势比(ORs)和95%置信区间的平均差异(ci)。结果:我们纳入了8项研究,共2072例患者,其中1025例(49.5%)患者为uACP组。合并分析显示,uACP与较短的住院时间相关(平均差异-2.2天;95% CI -3.6 ~ -0.7;结论:我们的荟萃分析证实了先前综述中报道的uACP和bACP之间的几个可比结果。然而,我们的研究还发现了其他发现,例如与uACP相关的住院时间缩短、永久性神经功能障碍发生率降低,以及急性肾损伤的风险增加。
{"title":"Unilateral Versus Bilateral Antegrade Cerebral Perfusion in Aortic Arch Surgery: Systematic Review and Meta-Analysis of Randomised Controlled Trials and Propensity-Matched Studies","authors":"Kristine Santos BSc ,&nbsp;Emmanuel Mark Velasco MD ,&nbsp;Mohammad Mawasi ,&nbsp;Tomasz Płonek MD, PhD, FEBCTS(cardiac)","doi":"10.1016/j.hlc.2025.03.018","DOIUrl":"10.1016/j.hlc.2025.03.018","url":null,"abstract":"<div><h3>Background</h3><div>Selective antegrade cerebral perfusion<span><span>, via unilateral antegrade cerebral perfusion (uACP) or bilateral antegrade cerebral perfusion (bACP) approaches, is used in aortic arch surgery to protect the brain during circulatory arrest. Previous meta-analyses, based on unmatched observational data, found no differences between these techniques. Our updated meta-analysis exclusively examines high-quality evidence from </span>randomised controlled trials and propensity-matched studies.</span></div></div><div><h3>Method</h3><div>A literature search of MEDLINE, Scopus, and Cochrane databases identified relevant studies up to November 2024. Pooled odds ratios (ORs) and mean differences with 95% confidence intervals (CIs) were calculated using RevMan version 8.13.0.</div></div><div><h3>Results</h3><div><span>We included eight studies comprising 2,072 patients, with 1,025 (49.5%) patients in the uACP group. The pooled analysis revealed that uACP was associated with a shorter hospital length of stay (mean differences −2.2 days; 95% CI −3.6 to −0.7; p&lt;0.05) and a reduced incidence of permanent neurological dysfunction (OR 0.7; 95% CI 0.5 to 0.9; p&lt;0.05). However, uACP was linked to a higher incidence of acute kidney injury (OR 1.5; 95% CI 1.1 to 2.0; p&lt;0.05). No statistically significant differences were observed between uACP and bACP in terms of aortic cross-clamp time, </span>cardiopulmonary bypass<span> duration, ventilation time, transient neurological deficits, intensive care unit<span> length of stay, 30-day mortality, and re-exploration for bleeding.</span></span></div></div><div><h3>Conclusions</h3><div>Our meta-analysis confirmed several comparable outcomes between uACP and bACP as reported in previous reviews. However, our study identified additional findings, such as a reduced hospital length of stay and lower incidence of permanent neurological dysfunction associated with uACP, alongside a higher risk of acute kidney injury.</div></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 11","pages":"Pages 1218-1227"},"PeriodicalIF":2.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144540047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Cardiac Output Measurement Techniques: Thermodilution Versus Biventricular Pressure-Volume Loop Recordings in Pigs 心输出量测量技术的比较:猪的热稀释与双心室压力-容量环路记录。
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-01 DOI: 10.1016/j.hlc.2025.05.080
Simone Juel Dragsbaek MD , Mathilde Emilie Kirk MD , Cecilie Dahl Baltsen BMSc , Asger Andersen MD, PhD , Mads Dam Lyhne MD, PhD

Background

Cardiac output (CO) measurement is crucial in cardiovascular research. Pressure-volume (PV) loop recordings provide detailed information on cardiac function, including CO. This study aimed to compare CO measurements obtained from biventricular PV loop recordings with thermodilution (TD) as a reference method in pigs.

Method

The TD-CO was measured by right heart catheterisation. The PV-derived CO was obtained from both ventricles simultaneously, both during ongoing ventilation and in transient apnoea. Data were compared using the Bland-Altman method. The percentage error (PE%) and linear regression were calculated between the TD-CO and PV-derived CO.

Results

Simultaneous CO measurements from 43 pigs were analysed. Compared to thermodilution, the lowest bias was found in PV-derived CO from the left ventricle during ongoing ventilation (0.02 L/min, 95% confidence interval [0.2–0.3]) with a PE% of 30% during ongoing ventilation. The highest bias was found in PV-derived CO from the right ventricle during ongoing ventilation (0.9 L/min, 95% CI [0.5–1.3]) with a PE% of 67% during ongoing ventilation.

Conclusions

PV-derived CO from the left ventricle showed very good agreement with TD-CO, with minimal bias, while PV-CO measurements from the right ventricle showed higher inaccuracy, likely due to anatomical differences between the ventricles.
背景:心输出量(CO)测量在心血管研究中至关重要。压力-体积(PV)环路记录提供了包括CO在内的心功能的详细信息。本研究旨在比较猪双心室PV环路记录和热稀释(TD)作为参考方法获得的CO测量值。方法:采用右心导管法测定TD-CO。在持续通气和短暂性呼吸暂停期间,pv衍生的CO同时从两个心室获得。数据比较采用Bland-Altman方法。计算了TD-CO和pv -CO之间的百分比误差(PE%)和线性回归。结果:分析了43头猪同时测量的CO。与热稀释相比,持续通气期间左心室pv衍生CO的偏差最低(0.02 L/min, 95%可信区间[0.2-0.3]),持续通气期间PE%为30%。在持续通气期间,来自右心室的pv衍生CO偏差最大(0.9 L/min, 95% CI[0.5-1.3]),在持续通气期间PE%为67%。结论:左心室PV-CO测量结果与TD-CO测量结果非常吻合,偏差很小,而右心室PV-CO测量结果的不准确性较高,可能是由于两心室解剖结构的差异。
{"title":"Comparison of Cardiac Output Measurement Techniques: Thermodilution Versus Biventricular Pressure-Volume Loop Recordings in Pigs","authors":"Simone Juel Dragsbaek MD ,&nbsp;Mathilde Emilie Kirk MD ,&nbsp;Cecilie Dahl Baltsen BMSc ,&nbsp;Asger Andersen MD, PhD ,&nbsp;Mads Dam Lyhne MD, PhD","doi":"10.1016/j.hlc.2025.05.080","DOIUrl":"10.1016/j.hlc.2025.05.080","url":null,"abstract":"<div><h3>Background</h3><div>Cardiac output (CO) measurement is crucial in cardiovascular research. Pressure-volume (PV) loop recordings provide detailed information on cardiac function, including CO. This study aimed to compare CO measurements obtained from biventricular PV loop recordings with thermodilution (TD) as a reference method in pigs.</div></div><div><h3>Method</h3><div>The TD-CO was measured by right heart catheterisation. The PV-derived CO was obtained from both ventricles simultaneously, both during ongoing ventilation and in transient apnoea. Data were compared using the Bland-Altman method. The percentage error (PE%) and linear regression were calculated between the TD-CO and PV-derived CO.</div></div><div><h3>Results</h3><div>Simultaneous CO measurements from 43 pigs were analysed. Compared to thermodilution, the lowest bias was found in PV-derived CO from the left ventricle during ongoing ventilation (0.02 L/min, 95% confidence interval [0.2–0.3]) with a PE% of 30% during ongoing ventilation. The highest bias was found in PV-derived CO from the right ventricle during ongoing ventilation (0.9 L/min, 95% CI [0.5–1.3]) with a PE% of 67% during ongoing ventilation.</div></div><div><h3>Conclusions</h3><div>PV-derived CO from the left ventricle showed very good agreement with TD-CO, with minimal bias, while PV-CO measurements from the right ventricle showed higher inaccuracy, likely due to anatomical differences between the ventricles.</div></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 11","pages":"Pages 1295-1300"},"PeriodicalIF":2.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144882790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thyrotropin Modulates Calcium Handling and Contractility in Adult Cardiac Myocytes 促甲状腺素调节成人心肌细胞钙处理和收缩性。
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-01 DOI: 10.1016/j.hlc.2025.07.009
Marisa Sepúlveda PhD , Florencia Racioppi PhD , Juan Ignacio Burgos PhD , Alexandra Murillo MD , Julieta Fernandez-Ruocco PhD , Luis Gonano PhD , Gabriel Neiman PhD , Santiago Miriuka PhD , Andrea Fellet PhD , Oscar Casis PhD , Emiliano Medei PhD , German Colareda PhD , Martín Vila Petroff PhD
{"title":"Thyrotropin Modulates Calcium Handling and Contractility in Adult Cardiac Myocytes","authors":"Marisa Sepúlveda PhD ,&nbsp;Florencia Racioppi PhD ,&nbsp;Juan Ignacio Burgos PhD ,&nbsp;Alexandra Murillo MD ,&nbsp;Julieta Fernandez-Ruocco PhD ,&nbsp;Luis Gonano PhD ,&nbsp;Gabriel Neiman PhD ,&nbsp;Santiago Miriuka PhD ,&nbsp;Andrea Fellet PhD ,&nbsp;Oscar Casis PhD ,&nbsp;Emiliano Medei PhD ,&nbsp;German Colareda PhD ,&nbsp;Martín Vila Petroff PhD","doi":"10.1016/j.hlc.2025.07.009","DOIUrl":"10.1016/j.hlc.2025.07.009","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 11","pages":"Pages e153-e156"},"PeriodicalIF":2.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145307937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Timing, Diagnosis, and Potential Preventability of 30-Day Unplanned Readmissions After a Heart Failure Hospitalisation: Implications for Care Quality 心衰住院后30天意外再入院的时机、诊断和潜在的可预防性:对护理质量的影响。
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-01 DOI: 10.1016/j.hlc.2025.04.085
James Fryar MD , Sunnya Khawaja MPH , Trang Dang MA, MHlthEcPol , Wandy Chan MBChB, PhD , Maryam Khorramshahi Bayat MD , William Parsonage BM, BS, DM , Isuru Ranasinghe MBChB, MMed(Clin Epi), PhD

Aim

To assess timing, causes, and potential preventability of unplanned readmissions within 30 days of heart failure hospitalisation and how they vary by age and sex across the population.

Method

We conducted a cohort study using hospitalisation data from 2013 to 2017 from all public and most private hospitals in Australia and New Zealand, including 197,648 patients aged ≥18 years (mean age 78.2 [standard deviation 12.3] years, 52.4% male, 13.3% <65 years) with a primary diagnosis of heart failure. The main outcomes included the timing of 30-day unplanned readmissions, the diagnoses associated with these, and their potential preventability. Preventability was determined by categorising readmission diagnoses into the following: 1) potential hospital-acquired complication, 2) recurrent heart failure, 3) clinically related to heart failure, and 4) all other diagnoses. Groups 1 and 2 were deemed most preventable.

Results

A total of 43,011 (21.8%) patients had one or more unplanned readmissions within 30 days. The peak readmission risk occurred on days 2–4 post-discharge with 25,318 (58.9%) occurring within 2 weeks. When grouped, diagnoses consistent with a potential hospital-acquired complication (group 1) accounted for 41.7% (most commonly pneumonia, atrial fibrillation/flutter, and myocardial infarction), readmission for recurrent heart failure (group 2) comprised 38.2%, and groups 3 and 4 consisted of 11.5% and 8.6%, respectively. Although heart failure hospitalisation occurred more frequently in older adults, the risk of readmission exceeded 20% in all age groups, and the timing and potential preventability were not clinically significantly different across age and sex.

Conclusions

The peak risk of unplanned readmission occurred in the first few days after discharge, often for potentially preventable reasons such as hospital-acquired complications and recurrent heart failure. Such early and potentially preventable readmissions suggest many may be related to suboptimal quality of hospital care and discharge practices. Future clinical and policy interventions should target improving hospital-based heart failure care quality to reduce avoidable readmissions.
目的:评估心力衰竭住院30天内意外再入院的时间、原因和潜在的可预防性,以及它们在人群中的年龄和性别差异。方法:采用2013 - 2017年澳大利亚和新西兰所有公立医院和大多数私立医院的住院数据进行队列研究,包括197,648例年龄≥18岁的患者(平均年龄78.2[标准差12.3]岁,男性52.4%,13.3%)。结果:共有43,011例(21.8%)患者在30天内出现一次或多次计划外再入院。再入院风险高峰发生在出院后2-4天,其中2周内发生25318例(58.9%)。分组时,诊断为潜在的医院获得性并发症(第1组)占41.7%(最常见的是肺炎、心房颤动/颤振和心肌梗死),因复发性心力衰竭再入院(第2组)占38.2%,第3组和第4组分别占11.5%和8.6%。尽管心力衰竭住院在老年人中发生的频率更高,但所有年龄组的再入院风险都超过20%,并且时间和潜在的可预防性在年龄和性别之间没有临床显着差异。结论:意外再入院的风险高峰发生在出院后的头几天,通常是由于潜在的可预防的原因,如医院获得性并发症和复发性心力衰竭。这种早期和潜在可预防的再入院表明,许多可能与医院护理和出院实践的次优质量有关。未来的临床和政策干预应以提高医院心力衰竭护理质量为目标,以减少可避免的再入院率。
{"title":"Timing, Diagnosis, and Potential Preventability of 30-Day Unplanned Readmissions After a Heart Failure Hospitalisation: Implications for Care Quality","authors":"James Fryar MD ,&nbsp;Sunnya Khawaja MPH ,&nbsp;Trang Dang MA, MHlthEcPol ,&nbsp;Wandy Chan MBChB, PhD ,&nbsp;Maryam Khorramshahi Bayat MD ,&nbsp;William Parsonage BM, BS, DM ,&nbsp;Isuru Ranasinghe MBChB, MMed(Clin Epi), PhD","doi":"10.1016/j.hlc.2025.04.085","DOIUrl":"10.1016/j.hlc.2025.04.085","url":null,"abstract":"<div><h3>Aim</h3><div>To assess timing, causes, and potential preventability of unplanned readmissions within 30 days of heart failure hospitalisation and how they vary by age and sex across the population.</div></div><div><h3>Method</h3><div>We conducted a cohort study using hospitalisation data from 2013 to 2017 from all public and most private hospitals in Australia and New Zealand, including 197,648 patients aged ≥18 years (mean age 78.2 [standard deviation 12.3] years, 52.4% male, 13.3% &lt;65 years) with a primary diagnosis of heart failure. The main outcomes included the timing of 30-day unplanned readmissions, the diagnoses associated with these, and their potential preventability. Preventability was determined by categorising readmission diagnoses into the following: 1) potential hospital-acquired complication, 2) recurrent heart failure, 3) clinically related to heart failure, and 4) all other diagnoses. Groups 1 and 2 were deemed most preventable.</div></div><div><h3>Results</h3><div>A total of 43,011 (21.8%) patients had one or more unplanned readmissions within 30 days. The peak readmission risk occurred on days 2–4 post-discharge with 25,318 (58.9%) occurring within 2 weeks. When grouped, diagnoses consistent with a potential hospital-acquired complication (group 1) accounted for 41.7% (most commonly pneumonia, atrial fibrillation/flutter, and myocardial infarction), readmission for recurrent heart failure (group 2) comprised 38.2%, and groups 3 and 4 consisted of 11.5% and 8.6%, respectively. Although heart failure hospitalisation occurred more frequently in older adults, the risk of readmission exceeded 20% in all age groups, and the timing and potential preventability were not clinically significantly different across age and sex.</div></div><div><h3>Conclusions</h3><div>The peak risk of unplanned readmission occurred in the first few days after discharge, often for potentially preventable reasons such as hospital-acquired complications and recurrent heart failure. Such early and potentially preventable readmissions suggest many may be related to suboptimal quality of hospital care and discharge practices. Future clinical and policy interventions should target improving hospital-based heart failure care quality to reduce avoidable readmissions.</div></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 11","pages":"Pages 1281-1289"},"PeriodicalIF":2.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144992335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Geographical and Temporal Variation in Coronary Intravascular Imaging Utilisation and Barriers to Wider Adoption: A Systematic Review and Pooled Analysis 冠状动脉血管内成像应用的地理和时间差异以及更广泛采用的障碍:系统回顾和汇总分析。
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-01 DOI: 10.1016/j.hlc.2025.04.086
Samuel Norman MChD , Anoop N. Koshy MBBS, PhD , Anna Wan MBBS , Sinjini Biswas MBBS, PhD , William Wilson MBBS , David Eccleston MBBS, MMedSci , Jeffrey Lefkovits MBBS

Background

Despite the accumulation of randomised data demonstrating improved outcomes with intravascular imaging (IVI)-guided percutaneous coronary intervention (PCI), utilisation is uncommon in most countries. This systematic review maps geographical and temporal trends in IVI use using PCI registry and government data.

Method

A systematic review adhering to the PRISMA framework was conducted to identify provincial, national, and international data sets reporting real-world IVI rates published between 2014 and 2024.

Results

A total of 36 publications from 24 countries were included, totalling 9,459,897 patients. Intravascular ultrasound was the preferred imaging modality, with optical coherence tomography accounting for <10% of IVI. Most countries reported low rates of IVI uptake, however, significant increases over time were observed. Rates varied significantly between and within regions and countries. Asia had the highest mean utilisation rate (35.4%; standard deviation, 35.9), followed by the Americas (9.3%; 5.7), Europe (5.7%; 4.9), and Oceania (4.5%; 2.6).

Conclusions

Significant variability in IVI utilisation was observed across regions and countries. Most countries reported low IVI rates; however, adoption increased over time in most areas. Local variables such as health care system characteristics, physician preferences, and financial considerations appear to inform IVI rates more than clinical factors.
背景:尽管累积的随机数据表明血管内成像(IVI)引导的经皮冠状动脉介入治疗(PCI)改善了结果,但在大多数国家,这种应用并不常见。本系统综述利用PCI登记和政府数据绘制了IVI使用的地理和时间趋势图。方法:遵循PRISMA框架进行系统评价,以确定2014年至2024年间发布的报告真实IVI率的省级、国家和国际数据集。结果:共纳入来自24个国家的36篇文献,共计9459897例患者。血管内超声是首选的成像方式,光学相干断层扫描解释了以下结论:不同地区和国家的IVI使用情况存在显著差异。大多数国家报告的体外注射率较低;然而,随着时间的推移,大多数地区的采用率都在增加。地方性变量,如卫生保健系统特征、医生偏好和财务考虑,似乎比临床因素更能影响IVI率。
{"title":"Geographical and Temporal Variation in Coronary Intravascular Imaging Utilisation and Barriers to Wider Adoption: A Systematic Review and Pooled Analysis","authors":"Samuel Norman MChD ,&nbsp;Anoop N. Koshy MBBS, PhD ,&nbsp;Anna Wan MBBS ,&nbsp;Sinjini Biswas MBBS, PhD ,&nbsp;William Wilson MBBS ,&nbsp;David Eccleston MBBS, MMedSci ,&nbsp;Jeffrey Lefkovits MBBS","doi":"10.1016/j.hlc.2025.04.086","DOIUrl":"10.1016/j.hlc.2025.04.086","url":null,"abstract":"<div><h3>Background</h3><div>Despite the accumulation of randomised data demonstrating improved outcomes with intravascular imaging (IVI)-guided percutaneous coronary intervention (PCI), utilisation is uncommon in most countries. This systematic review maps geographical and temporal trends in IVI use using PCI registry and government data.</div></div><div><h3>Method</h3><div>A systematic review adhering to the PRISMA framework was conducted to identify provincial, national, and international data sets reporting real-world IVI rates published between 2014 and 2024.</div></div><div><h3>Results</h3><div>A total of 36 publications from 24 countries were included, totalling 9,459,897 patients. Intravascular ultrasound was the preferred imaging modality, with optical coherence tomography accounting for &lt;10% of IVI. Most countries reported low rates of IVI uptake, however, significant increases over time were observed. Rates varied significantly between and within regions and countries. Asia had the highest mean utilisation rate (35.4%; standard deviation, 35.9), followed by the Americas (9.3%; 5.7), Europe (5.7%; 4.9), and Oceania (4.5%; 2.6).</div></div><div><h3>Conclusions</h3><div>Significant variability in IVI utilisation was observed across regions and countries. Most countries reported low IVI rates; however, adoption increased over time in most areas. Local variables such as health care system characteristics, physician preferences, and financial considerations appear to inform IVI rates more than clinical factors.</div></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 11","pages":"Pages 1179-1193"},"PeriodicalIF":2.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145069439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A 10-Year Review of Intravascular Imaging Use in Australia: Findings From a Statewide Registry 澳大利亚血管内成像使用的10年回顾:来自全州登记的发现。
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-01 DOI: 10.1016/j.hlc.2025.08.017
Arun Sharma MD, B.Biomed , Riley J. Batchelor MMed, FRACP , Diem Dinh PhD, BAppSc , Angela Brennan CCRN , Sinjini Biswas PhD, FRACP , Simon Thackray MBBS , Jacob Park MD , Samuel Norman MChd, FRACP , William Wilson FRACP , Ronen Gurvitch FRACP , Dion Stub PhD, FRACP , Jeffrey Lefkovits FRACP, FCSANZ , Anoop N. Koshy PhD, FRACP

Background

In several recent randomised trials, intravascular imaging (IVI)-guided percutaneous intervention (PCI) has demonstrated superiority to angiography-guided PCI, particularly, in certain lesion subsets. Given the recent Medicare Benefits Schedule (MBS) criteria changes to incorporate intravascular ultrasound (IVUS) for PCI, we sought to report the real-world use of IVI.

Methods

Consecutive patients undergoing PCI entered into the Victorian Cardiac Outcomes Registry from 2013 to 2022 were included. Patients presenting with cardiogenic shock or out-of-hospital cardiac arrest requiring intubation were excluded given their distinct clinical urgency and unstable physiology. The overall use of either IVUS and optical coherence tomography (OCT) was assessed. Additionally, we assessed the use of IVI in PCI in scenarios as per MBS criteria: lesion length ≥28 mm (using stent length as a surrogate marker) and left main PCI, as well as in cases of in-stent restenosis.

Results

A total of 104,722 PCI procedures were included. IVUS/OCT was used in 3,137 (3.0%) cases. There was a significant increase in rates of IVI-PCI over the study period, increasing from 2.2% (n=105 of 4,809) in 2013 to 6.3% (n=730 of 11,651) in 2022 (p=0.005). Comparing 2013–2017 with 2018–2022, there was a significant increase in IVUS/OCT use for left main disease (p=0.01) and PCIs with stent length ≥28 mm (p=0.001). Of the 39,492 PCI cases with stent length ≥28 mm, IVUS/OCT was used in 3.3% of cases (1,313), with these patients being younger (p=0.001) and more likely to have diabetes (p=0.001) and previous PCI (p=0.001). Of the 1,831 left main PCI cases, IVI was used in 460 (25.1%).

Conclusions

Although IVI use has grown significantly, 75% of left main coronary artery PCIs have still been done without imaging. With recent MBS changes, we anticipate further growth for IVI-guided PCI.
背景:在最近的几项随机试验中,血管内成像(IVI)引导下的经皮介入治疗(PCI)已被证明优于血管造影引导下的PCI,特别是在某些病变亚群中。鉴于最近医疗保险福利计划(MBS)标准的改变,纳入了血管内超声(IVUS)进行PCI,我们试图报告IVI在现实世界中的应用。方法:纳入2013年至2022年在维多利亚心脏结局登记处连续接受PCI治疗的患者。因心源性休克或院外心脏骤停需要插管的患者被排除在外,因为他们具有明显的临床紧迫性和不稳定的生理。评估IVUS和光学相干断层扫描(OCT)的总体使用情况。此外,我们根据MBS标准评估了IVI在PCI中的使用情况:病变长度≥28 mm(使用支架长度作为替代标记)和左主干PCI,以及支架内再狭窄的情况。结果:共纳入104,722例PCI手术。3137例(3.0%)采用IVUS/OCT。在研究期间,IVI-PCI发生率显著增加,从2013年的2.2%(4809例中n=105例)增加到2022年的6.3%(11651例中n=730例)(p=0.005)。2013-2017年与2018-2022年相比,左主干病变IVUS/OCT的使用率显著增加(p=0.01),支架长度≥28 mm的pci使用率显著增加(p=0.001)。在39492例支架长度≥28 mm的PCI病例中,3.3%(1313例)使用了IVUS/OCT,这些患者年龄较小(p=0.001),更容易患有糖尿病(p=0.001)和既往PCI (p=0.001)。1831例左主干PCI患者中,460例(25.1%)采用IVI。结论:尽管IVI的使用显著增加,但75%的左主干冠状动脉pci仍未进行影像学检查。随着最近MBS的变化,我们预计ivi引导的PCI将进一步增长。
{"title":"A 10-Year Review of Intravascular Imaging Use in Australia: Findings From a Statewide Registry","authors":"Arun Sharma MD, B.Biomed ,&nbsp;Riley J. Batchelor MMed, FRACP ,&nbsp;Diem Dinh PhD, BAppSc ,&nbsp;Angela Brennan CCRN ,&nbsp;Sinjini Biswas PhD, FRACP ,&nbsp;Simon Thackray MBBS ,&nbsp;Jacob Park MD ,&nbsp;Samuel Norman MChd, FRACP ,&nbsp;William Wilson FRACP ,&nbsp;Ronen Gurvitch FRACP ,&nbsp;Dion Stub PhD, FRACP ,&nbsp;Jeffrey Lefkovits FRACP, FCSANZ ,&nbsp;Anoop N. Koshy PhD, FRACP","doi":"10.1016/j.hlc.2025.08.017","DOIUrl":"10.1016/j.hlc.2025.08.017","url":null,"abstract":"<div><h3>Background</h3><div>In several recent randomised trials, intravascular imaging (IVI)-guided percutaneous intervention (PCI) has demonstrated superiority to angiography-guided PCI, particularly, in certain lesion subsets. Given the recent Medicare Benefits Schedule (MBS) criteria changes to incorporate intravascular ultrasound (IVUS) for PCI, we sought to report the real-world use of IVI.</div></div><div><h3>Methods</h3><div>Consecutive patients undergoing PCI entered into the Victorian Cardiac Outcomes Registry from 2013 to 2022 were included. Patients presenting with cardiogenic shock or out-of-hospital cardiac arrest requiring intubation were excluded given their distinct clinical urgency and unstable physiology. The overall use of either IVUS and optical coherence tomography (OCT) was assessed. Additionally, we assessed the use of IVI in PCI in scenarios as per MBS criteria: lesion length ≥28 mm (using stent length as a surrogate marker) and left main PCI, as well as in cases of in-stent restenosis.</div></div><div><h3>Results</h3><div>A total of 104,722 PCI procedures were included. IVUS/OCT was used in 3,137 (3.0%) cases. There was a significant increase in rates of IVI-PCI over the study period, increasing from 2.2% (n=105 of 4,809) in 2013 to 6.3% (n=730 of 11,651) in 2022 (p=0.005). Comparing 2013–2017 with 2018–2022, there was a significant increase in IVUS/OCT use for left main disease (p=0.01) and PCIs with stent length ≥28 mm (p=0.001). Of the 39,492 PCI cases with stent length ≥28 mm, IVUS/OCT was used in 3.3% of cases (1,313), with these patients being younger (p=0.001) and more likely to have diabetes (p=0.001) and previous PCI (p=0.001). Of the 1,831 left main PCI cases, IVI was used in 460 (25.1%).</div></div><div><h3>Conclusions</h3><div>Although IVI use has grown significantly, 75% of left main coronary artery PCIs have still been done without imaging. With recent MBS changes, we anticipate further growth for IVI-guided PCI.</div></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 11","pages":"Pages 1235-1240"},"PeriodicalIF":2.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145137310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Braess's Network Paradox in Coronary and Vascular Revascularisation: Adding Game Theory to Virchow’s Triad 冠状动脉和血管重建中的Braess网络悖论:将博弈论添加到Virchow的三合一中
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-01 DOI: 10.1016/j.hlc.2025.04.094
Hutan Ashrafian MBBS, PhD, MBA
{"title":"Braess's Network Paradox in Coronary and Vascular Revascularisation: Adding Game Theory to Virchow’s Triad","authors":"Hutan Ashrafian MBBS, PhD, MBA","doi":"10.1016/j.hlc.2025.04.094","DOIUrl":"10.1016/j.hlc.2025.04.094","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"34 11","pages":"Pages e164-e166"},"PeriodicalIF":2.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145478820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Heart, Lung and Circulation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1